The HPV vaccine, particularly Merck’s Gardasil, is deemed very safe and effective in preventing cervical cancer, supported by extensive research, including nearly 60 clinical trials and 225 observational studies involving over 132 million people. Vaccinating girls before age 16 can reduce cervical cancer risk by 80%, with real-world data showing a significant decline in cervical cancer rates in vaccinated populations. Concerns about adverse effects, such as infertility, have been dismissed by recent studies, reinforcing the vaccine’s safety. The CDC recommends vaccination for adolescents aged 11 to 12, highlighting its role in preventing HPV-related cancers.
Loading PerspectiveSplit analysis...
